Medical abortion: A path to safe, high-quality abortion care in Latin America and the Caribbean

REFERENCES

• WHO. The prevention and management of unsafe abortion: Report of a technical working group. Geneva, Switzerland: Division of Family Health, World Health Organization 1992.
   Google Scholar
• Sedgh G, Singh S, Shah IH, et al. Induced abortion: Incidence and trends worldwide from 1995 to 2008. Lancet 2012;379:625–32.
   PubMed Web of Science ®Google Scholar
• Sedgh G, Henshaw S, Singh S, et al. Induced abortion: Estimated rates and trends worldwide. Lancet 2007; 370:1338–45.
   PubMed Web of Science ®Google Scholar
• Bongaarts J, Westhoff CF. The potential role of contraception in reducing abortion. Stud Fam Plann 2000;31: 193–202.
   PubMed Web of Science ®Google Scholar
• Tietze C, Bongaarts J. The demographic effect of induced abortion. Obstet Gynecol Surv 1976;31:699–709.
   PubMedGoogle Scholar
• Requena M. Social and economic correlates of induced abortion in Santiago, Chile. Demography 1965; 2:33–49.
   Web of Science ®Google Scholar
• Trussell J. Contraceptive efficacy. In: Hatcher RA, Trussell J, Nelson AL, et al, eds. Contraceptive technology, 19th edn. New York: Ardent Publisher 2007.
   Google Scholar
• WHO. Unsafe abortion. Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008, 6th edn. Geneva: World Health Organization 2011.
   Google Scholar
• Guttmacher Institute. Facts on abortion in Latin America and the Caribbean, In Brief, New York: Guttmacher Institute, 2012. Accessed 16 April 2002 from: http://www.guttmacher.org/pubs/IB_AWW-Latin-America.pdf
   Google Scholar
• Gonzalez Velez AC. Una mirada analitica a la legislación sobre interrupción del embarazo en paises de Iberoamérica y el Caribe. Santiago de Chile: Naciones Unidas CEPAL 2011.
   Google Scholar
• Center for Reproductive Rights. The World's Abortion Laws 2012. New York: Center for Reproductive Rights 2011. Accessed 7 July 2013 from: www.world abortionlaws.com
   Google Scholar
• Constitución Política de la República Dominicana [CP] art. 37. Santo Domingo, República Dominicana: Gobierno de la República Dominicana 2010.
   Google Scholar
• GIRE. Reformas aprobadas a las constituciones estatales que protegen la vida desde la concepción/fecundación 2008–2011. Mexico City: Grupo de Información en Reproducción Elegida 2012. Accessed 18 June 2013 from: https://www.gire.org.mx/images/stories/ley/ReformasAbortoConstitucion_270712.pdf.
   Google Scholar
• Creinin MD. Medical abortion regimens: Historical context and overview. Am J Obstet Gynecol 2000;183: S3–9.
   PubMedGoogle Scholar
• Winikoff B, Sivin I, Coyaji KJ, et al. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: A comparative trial of mifepristone-misoprostol versus surgical abortion. Am J Obstet Gynecol 1997; 176:431–7.
   PubMed Web of Science ®Google Scholar
• Swica Y, Raghavan S, Bracken H, et al. Review of the literature on patient satisfaction with early medical abortion using mifepristone and misoprostol. Expert Rev Obstet Gynecol 2011;6:451–68.
   Google Scholar
• WHO. Safe abortion: Technical and policy guidance for health systems, 2nd edn. Geneva: World Health Organization 2012.
   Google Scholar
• FLASOG. El Uso de Misoprostol en Obstetrica y Ginecologia, 2nd edn. Federación Latino Americana de Sociedades de Obstetrica y Ginecologia 2007.
   Google Scholar
• Yarnall J, Swica Y, Winikoff B. Non-physician clinicians can safely provide first trimester medical abortion. Reprod Health Matters 2009;17:61–9.
   PubMed Web of Science ®Google Scholar
• Renner RM, Brahmi D, Kapp N. Who can provide effective and safe termination of pregnancy care? A systematic review. BJOG 2013;120:23–31.
   PubMed Web of Science ®Google Scholar
• Warriner IK, Wang D, Huong NT, et al. Can midlevel health-care providers administer early medical abortion as safely and effectively as doctors? A randomised controlled equivalence trial in Nepal. Lancet 2011;377: 1155–61.
   PubMed Web of Science ®Google Scholar
• Blum J, Raghavan S, Dabash R, et al. Comparison of misoprostol-only and combined mifepristone- misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam. Int J Gynaecol Obstet 2012;118:166–71.
   PubMed Web of Science ®Google Scholar
• Távara-Orozco L, Chávez S, Grossman D, et al. Disponibilidad y uso obstétrico del misoprostol en los países de América Latina y el Caribe. Rev Per Ginecol Obstet 2008;54:253–63.
   Google Scholar
• Fernandez M, Coeytaux F, Ponce de Léon RG, Harrison D. Assessing the global availability of misoprostol. Int J Gynaecol Obstet 2009;105:180–6.
   PubMed Web of Science ®Google Scholar
• Paulo LG, Zanini AC. Auto medicação no Brasil. Rev Ass Med Brasil 1988;34:69–75.
   Google Scholar
• Barbosa RM, Arilha M. The Brazilian experience with cytotec. Stud Fam Plann 1993;24:236–40.
   PubMed Web of Science ®Google Scholar
• Coelho HL. Letter to the editor: Selling abortifacients over the counter in pharmacies in Fortaleza, Brazil. Lancet 1991;338:247.
   PubMed Web of Science ®Google Scholar
• Harper CC, Blanchard K, Grossman D, et al. Reducing maternal mortality due to elective abortion: Potential impact of misoprostol in low-resource settings. Int J Gynaecol Obstet 2007;98:66–9.
   PubMed Web of Science ®Google Scholar
• Ahman E, Shah IH. New estimates and trends regarding unsafe abortion mortality. Int J Gynaecol Obstet 2011; 115:121–6.
   PubMed Web of Science ®Google Scholar
• WHO. Unsafe abortion. Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2000, 4th edn. Geneva: World Health Organization 2004.
   Google Scholar
• Lafaurie MM, Grossman D, Troncoso E, et al. Women's perspectives on medical abortion in Mexico, Colombia, Ecuador and Peru: A qualitative study. Reprod Health Matters 2005;13:75–83.
   PubMed Web of Science ®Google Scholar
• Juarez F, Singh S, Garcia SG, Olavarrieta CD. Estimates of induced abortion in Mexico: What's changed between 1990 and 2006?Int Fam Plann Perspect 2008;34:158–68.
   PubMedGoogle Scholar
• Barreto T, Campbell OM, Davies JL, et al. Investigating induced abortion in developing countries: Methods and problems. Stud Fam Plann 2003;23:159–70.
   Google Scholar
• Rossier C. Estimating induced abortion rates: A review. Stud Fam Plann 2003;34:87–102.
   PubMed Web of Science ®Google Scholar
• Wilson KA, Garcia SG, Lara D. Misoprostol use and its impact on measuring abortion incidence and morbidity. In: Singh S, Remez L, Tartaglione A, eds. Methodologies for estimating abortion incidence and abortion-related morbidity: A review. New York and Paris: Guttmacher Institute, International Union for the Scientific Study of Population 2010.
   Google Scholar
• Costa SH, Vessey MP. Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet 1993;341:1258–61.
   PubMed Web of Science ®Google Scholar
• Costa S. Commercial availability of misoprostol and induced abortion in Brazil. Int J Gynaecol Obstet 1998;63:S131–9.
   PubMed Web of Science ®Google Scholar
• Misago C, Fonseca W, Correia L, et al. Determinants of abortion among women admitted to hospitals in Fortaleza, North Eastern Brazil. Int J Epidemiol 1998; 27:833–9.
   PubMed Web of Science ®Google Scholar
• Faúndes A, Santos LC, Carvalho M, Gras C. Post- abortion complications after interruption of pregnancy with misoprostol. Adv Contracept 1996;12:1–9.
   PubMedGoogle Scholar
• Faúndes A. Misoprostol: life-saving. Eur J Contracept Reprod Health Care 2011;16:57–60.
   PubMed Web of Science ®Google Scholar
• Briozzo L, Vidiella G, Rodríguez F, et al. A risk reduction strategy to prevent maternal deaths associated with unsafe abortion. Int J Gynaecol Obstet 2006;95:221–6.
   PubMed Web of Science ®Google Scholar
• Vlassoff M, Walker D, Shearer J, et al. Estimates of health care system costs of unsafe abortion in Africa and Latin America. Int Perspect Sex Reprod Health 2009;35:114–21.
   PubMed Web of Science ®Google Scholar
• Levin C, Grossman D, Berdichevsky K, et al. Exploring the costs and economic consequences of unsafe abortion in Mexico City before legalisation. Reprod Health Matters 2009;17:120–32.
   PubMed Web of Science ®Google Scholar
• Briozzo L. Iniciativas Sanitarias: Una nueva estrategia en el abordaje del aborto de riesgo. In: Briozzo L, ed. Iniciativas Sanitarias: Contra el aborto provocado en condiciones de riesgo. Montevideo, Uruguay: Editorial Arena 2007.
   Google Scholar
• Erdman JN. Access to information on safe abortion: A harm reduction and human rights approach. Harvard J Law Gender 2011;34:413–62.
   Google Scholar
• Carino G, Friedman J, Rueda Gomez M, et al. A rights-based model: Perspectives from health service providers. Inst Dev Stud 2008;39:77–82.
   Web of Science ®Google Scholar
• Briozzo L, Vidiella G, Vidarte B, et al. Induced abortion under unsafe conditions. Health emergencies and maternal mortality in Uruguay. The current situation and medical initiatives for safe motherhood. Rev Med Uruguay 2002;18:4–14.
   Google Scholar
• Lesbianas y feministas por la descriminalización del aborto. Las mujeres ya decidieron que el aborto es legal. Quinto informe de atención de la línea aborto: Más información, menos riesgos. 2012. Accessed 19 February 2013 from: http://abortoconpastillas.info/wp-content/uploads/2013/01/LAS-MUJERES-YA-DECIDIERON-QUE-EL-ABORTO-ES-LEGAL-15-12-12.pdf.
   Google Scholar
• Gomperts R, Jelinska K, Davies S, et al. Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services. BJOG 2008;115:1171–8.
   PubMed Web of Science ®Google Scholar
• Gomperts R, Petow SA, Jelinska K, et al. Regional differences in surgical intervention following medical termination of pregnancy provided by telemedicine. Acta Obstet Gynecol Scand 2011;91:226–31.
   PubMed Web of Science ®Google Scholar
• Aldrich T, Winikoff B. Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions. BJOG 2007;114:555–62.
   PubMed Web of Science ®Google Scholar
• Billings DL. Misoprostol alone for early medical abortion in a Latin American clinic setting. Reprod Health Matters 2004;12:57–64.
   PubMed Web of Science ®Google Scholar
• Boersma AA, Meyboom-de Jong B, Kleiverda G. Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaçao. Eur J Contracept Reprod Health Care 2011;16:61–6.
   PubMed Web of Science ®Google Scholar
• Sayette H, Redwine D, Sivin I, et al. Buccal use of misoprostol alone for early abortion: The experience in four Latin American countries. Contraception 2011; 84:304.
   Web of Science ®Google Scholar
• van Dijk MG, Arellano Mendoza LJ, Arangure Peraza AG, et al. Women's experiences with legal abortion in Mexico City: A qualitative study. Stud Fam Plann 2011;42:167–74.
   PubMed Web of Science ®Google Scholar
• Winikoff B, Dzuba IG, Chong E, et al. Extending outpatient medical abortion services through 70 days of gestational age. Obstet Gynecol 2012;120:1070–6.
   PubMed Web of Science ®Google Scholar
• Díaz Pasten S. El uso de las prostaglandinas en obstetricia y ginecología: el caso del misoprostol. San Jose, Costa Rica: Asociación Colectiva por el Derecho a Decidir 2011.
   Google Scholar
• Ministerio de Salud, Dirección de Regulación de la Salud, Unidad de Control. Misoprostol tabletas de 200 mcg. San Jose, Costa Rica 2009. Accessed 27 December 2012 from: http://www.colfar.com/biblioteca-virtual.php?cat0=13.
   Google Scholar
• Kestler E. Obstetrician-gynecologists’ knowledge of and attitudes toward medical abortion in Guatemala. Int J Gynaecol Obstet 2012;116:120–3.
   PubMed Web of Science ®Google Scholar
• Faúndes A, Rao K, Briozzo L. Right to protection from unsafe abortion and postabortion care. Int J Gynaecol Obstet 2009;106:164–7.
   PubMed Web of Science ®Google Scholar
• Yam EA, Dries-Daffner I, Garcia SG. Abortion opinion research in Latin America and the Caribbean: A review of the literature. Stud Fam Plann 2006;37: 225–40.
   PubMed Web of Science ®Google Scholar
• Garcia S, Lara D, Goldman L. Conocimientos, actitudes y prácticas de los médicos mexicanos sobre el aborto: resultados de una encuesta nacional. Gac Méd México 2003;139:11.
   Google Scholar
• Contreras X, van Dijk MG, Sanchez T, Sanhueza Smith P. Experiences and opinions of health-care professionals regarding legal abortion in Mexico City: A qualitative study. Stud Fam Plann 2011;42:183–90.
   PubMed Web of Science ®Google Scholar
• Corte Constitucional (Colombia), Sentencia C-355; 10 May 2006. Accessed 27 December 2012 from: http://www.corteconstitucional.gov.co/relatoria/2006/c-355-06.htm
   Google Scholar
• Prada E, Sing S, Remez L, Villareal C. Unintended pregnancy and induced abortion in Colombia: Causes and consequences. New York: Guttmacher Institute 2011.
   Google Scholar